State Of Wisconsin Investment Board Denali Therapeutics Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

A detailed history of State Of Wisconsin Investment Board transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 81,451 shares of DNLI stock, worth $2.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

81,451

Previous 76,931 5.88%

Holding current value

$2.01 Million

Previous $1.79 Million 32.81%

% of portfolio

0.01%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.96 - $31.05 $94,739 - $140,346	4,520 Added 5.88%	81,451 $2.37 Million
Q2 2024 Aug 14, 2024	SELL	$14.96 - $23.22 $51,791 - $80,387	-3,462 Reduced 4.31%	76,931 $1.79 Million
Q1 2024 May 14, 2024	SELL	$15.83 - $23.35 $176,156 - $259,838	-11,128 Reduced 12.16%	80,393 $1.65 Million
Q4 2023 Feb 12, 2024	SELL	$16.2 - $23.18 $102,627 - $146,845	-6,335 Reduced 6.47%	91,521 $1.96 Million
Q3 2023 Nov 14, 2023	SELL	$20.63 - $30.17 $15,121 - $22,114	-733 Reduced 0.74%	97,856 $2.02 Million
Q2 2023 Aug 14, 2023	BUY	$23.37 - $32.96 $251,531 - $354,748	10,763 Added 12.25%	98,589 $2.91 Million
Q1 2023 May 15, 2023	BUY	$21.91 - $32.67 $27,606 - $41,164	1,260 Added 1.46%	87,826 $2.02 Million
Q4 2022 Feb 14, 2023	SELL	$26.28 - $33.92 $26,017 - $33,580	-990 Reduced 1.13%	86,566 $2.41 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $10,829 - $16,067	417 Added 0.48%	87,556 $2.69 Million
Q2 2022 Aug 15, 2022	SELL	$20.88 - $35.19 $723,721 - $1.22 Million	-34,661 Reduced 28.46%	87,139 $2.57 Million
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $93,698 - $121,044	-2,200 Reduced 1.77%	121,800 $5.43 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $63,023 - $101,699	1,300 Added 1.06%	124,000 $6.26 Million
Q2 2021 Aug 12, 2021	BUY	$50.3 - $78.44 $1.66 Million - $2.59 Million	33,000 Added 36.79%	122,700 $9.63 Million
Q1 2021 May 17, 2021	SELL	$53.8 - $81.53 $193,680 - $293,508	-3,600 Reduced 3.86%	89,700 $5.12 Million
Q4 2020 Feb 03, 2021	SELL	$36.89 - $93.56 $280,364 - $711,056	-7,600 Reduced 7.53%	93,300 $7.82 Million
Q3 2020 Nov 16, 2020	BUY	$23.13 - $38.84 $416,340 - $699,120	18,000 Added 21.71%	100,900 $3.62 Million
Q2 2020 Aug 12, 2020	BUY	$16.01 - $28.82 $36,823 - $66,286	2,300 Added 2.85%	82,900 $2.01 Million
Q1 2020 May 06, 2020	BUY	$14.2 - $27.98 $123,540 - $243,426	8,700 Added 12.1%	80,600 $1.41 Million
Q3 2019 Nov 12, 2019	BUY	$15.32 - $21.92 $87,324 - $124,944	5,700 Added 8.61%	71,900 $1.1 Million
Q2 2019 Aug 14, 2019	BUY	$18.5 - $28.14 $83,250 - $126,630	4,500 Added 7.29%	66,200 $1.37 Million
Q1 2019 May 13, 2019	BUY	$17.99 - $24.65 $253,658 - $347,565	14,100 Added 29.62%	61,700 $1.43 Million
Q4 2018 Feb 11, 2019	BUY	$13.88 - $21.75 $8,328 - $13,050	600 Added 1.28%	47,600 $983,000
Q3 2018 Nov 14, 2018	BUY	$12.46 - $21.74 $585,620 - $1.02 Million	47,000 New	47,000 $1.02 Million

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account

State Of Wisconsin Investment Board Denali Therapeutics Inc. Transaction History